Compound Detail
CHEMBL4785581
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4785581 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZNZJGPOIIZTLFU-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
463.4
MW (Da)
4.36
ALogP
7
HBA
1
HBD
102.9
PSA (Ų)
0.47
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.02
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 5.02 | 5.02 | 9500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 9500.0 | nM | 5.02 | Inhibition of SOCE channel in tBhQ-treated HEK cells assessed as reduction in ca... | 33854704 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33854704 | 10.1021/acsmedchemlett.1c00034 | Unchecked | 3 |
| 33854704 | 10.1021/acsmedchemlett.1c00034 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine